Lv1
25 积分 2021-01-11 加入
Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
2个月前
已完结
Tumor‐Informed ctDNA in Guiding First‐Line Immunochemotherapy in Advanced Non‐Small Cell Lung Cancers
2个月前
已完结
Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer – A phase II study
5个月前
已完结
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapy
6个月前
已完结
Isolated nodal failure in stage III non-small-cell lung cancer after proton therapy with or without durvalumab
6个月前
已关闭
Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysis
6个月前
已关闭
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
6个月前
已完结
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
6个月前
已完结
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
7个月前
已完结
皖公网安备34019202002308
